Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 12 | 2025 | 1019 | 1.310 |
Why?
|
| Sexual Behavior | 11 | 2021 | 634 | 1.290 |
Why?
|
| Receptors, Nicotinic | 2 | 2020 | 114 | 1.140 |
Why?
|
| Child Abuse | 6 | 2014 | 90 | 0.900 |
Why?
|
| Thermogenesis | 3 | 2021 | 24 | 0.860 |
Why?
|
| Heterosexuality | 9 | 2021 | 96 | 0.830 |
Why?
|
| Bisexuality | 8 | 2018 | 210 | 0.810 |
Why?
|
| Homosexuality, Female | 6 | 2018 | 60 | 0.790 |
Why?
|
| Gender Identity | 3 | 2021 | 117 | 0.780 |
Why?
|
| Substance-Related Disorders | 5 | 2021 | 825 | 0.690 |
Why?
|
| Signal Transduction | 3 | 2020 | 2111 | 0.660 |
Why?
|
| Cell Communication | 1 | 2018 | 110 | 0.540 |
Why?
|
| rho-Associated Kinases | 3 | 2025 | 35 | 0.530 |
Why?
|
| Longitudinal Studies | 12 | 2019 | 1020 | 0.520 |
Why?
|
| Obesity | 6 | 2025 | 1131 | 0.510 |
Why?
|
| Body Mass Index | 5 | 2014 | 916 | 0.440 |
Why?
|
| Adult | 30 | 2025 | 13458 | 0.410 |
Why?
|
| Adolescent | 23 | 2025 | 5950 | 0.410 |
Why?
|
| Humans | 48 | 2025 | 42163 | 0.410 |
Why?
|
| Female | 38 | 2025 | 24018 | 0.400 |
Why?
|
| Suicide | 3 | 2023 | 139 | 0.400 |
Why?
|
| Nurses | 5 | 2018 | 55 | 0.380 |
Why?
|
| Restaurants | 3 | 2017 | 39 | 0.380 |
Why?
|
| Young Adult | 19 | 2025 | 4936 | 0.380 |
Why?
|
| United States | 17 | 2025 | 5072 | 0.380 |
Why?
|
| Sex Offenses | 3 | 2012 | 43 | 0.370 |
Why?
|
| Alcohol Drinking | 3 | 2019 | 585 | 0.360 |
Why?
|
| Spouse Abuse | 2 | 2012 | 51 | 0.360 |
Why?
|
| Child | 16 | 2019 | 3381 | 0.350 |
Why?
|
| Domestic Violence | 1 | 2011 | 32 | 0.340 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 159 | 0.340 |
Why?
|
| Overweight | 2 | 2014 | 248 | 0.330 |
Why?
|
| Subcutaneous Fat | 2 | 2021 | 18 | 0.320 |
Why?
|
| Cohort Studies | 10 | 2019 | 1729 | 0.320 |
Why?
|
| Child Development | 1 | 2011 | 95 | 0.320 |
Why?
|
| Acetylcholine | 2 | 2021 | 76 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 1804 | 0.270 |
Why?
|
| Single-Parent Family | 1 | 2007 | 5 | 0.270 |
Why?
|
| Parenting | 2 | 2007 | 135 | 0.260 |
Why?
|
| Alcoholism | 2 | 2021 | 292 | 0.260 |
Why?
|
| Stress, Psychological | 2 | 2025 | 641 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2015 | 1574 | 0.240 |
Why?
|
| Male | 22 | 2025 | 22779 | 0.240 |
Why?
|
| Mothers | 2 | 2009 | 212 | 0.240 |
Why?
|
| Social Class | 2 | 2007 | 286 | 0.240 |
Why?
|
| Socialization | 1 | 2025 | 20 | 0.230 |
Why?
|
| Casein Kinase II | 1 | 2025 | 16 | 0.230 |
Why?
|
| Women's Health | 2 | 2017 | 158 | 0.230 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2024 | 49 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2025 | 547 | 0.220 |
Why?
|
| Photosensitizing Agents | 1 | 2024 | 55 | 0.220 |
Why?
|
| Health Status | 2 | 2008 | 432 | 0.220 |
Why?
|
| Hydrogels | 1 | 2024 | 55 | 0.220 |
Why?
|
| Military Personnel | 1 | 2025 | 109 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1617 | 0.210 |
Why?
|
| Self Disclosure | 1 | 2004 | 43 | 0.210 |
Why?
|
| Sexuality | 2 | 2014 | 56 | 0.210 |
Why?
|
| Animals | 11 | 2025 | 16695 | 0.200 |
Why?
|
| Health Status Indicators | 1 | 2004 | 90 | 0.200 |
Why?
|
| Neurogenesis | 2 | 2021 | 64 | 0.200 |
Why?
|
| Income | 1 | 2004 | 160 | 0.190 |
Why?
|
| Logistic Models | 4 | 2012 | 1001 | 0.190 |
Why?
|
| Time Factors | 5 | 2015 | 1848 | 0.190 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2023 | 70 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 744 | 0.180 |
Why?
|
| Telemedicine | 1 | 2025 | 215 | 0.180 |
Why?
|
| Choice Behavior | 3 | 2017 | 91 | 0.180 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2021 | 35 | 0.180 |
Why?
|
| Mice | 6 | 2025 | 6490 | 0.180 |
Why?
|
| Risk Factors | 11 | 2019 | 3942 | 0.180 |
Why?
|
| Child Abuse, Sexual | 2 | 2012 | 22 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 19 | 0.180 |
Why?
|
| Poverty | 1 | 2004 | 395 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 471 | 0.170 |
Why?
|
| Health Promotion | 2 | 2017 | 691 | 0.170 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2020 | 1 | 0.170 |
Why?
|
| Creatine | 1 | 2020 | 10 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2020 | 35 | 0.160 |
Why?
|
| Body Image | 1 | 2021 | 87 | 0.160 |
Why?
|
| Age Factors | 5 | 2019 | 1139 | 0.160 |
Why?
|
| Adipokines | 1 | 2020 | 25 | 0.160 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 82 | 0.160 |
Why?
|
| Lipoylation | 1 | 2019 | 17 | 0.160 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2010 | 25 | 0.160 |
Why?
|
| Family Relations | 1 | 2019 | 46 | 0.150 |
Why?
|
| Diet | 2 | 2016 | 810 | 0.150 |
Why?
|
| Adipose Tissue, Brown | 1 | 2019 | 39 | 0.150 |
Why?
|
| Commerce | 2 | 2017 | 95 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 206 | 0.150 |
Why?
|
| Prevalence | 6 | 2012 | 1597 | 0.150 |
Why?
|
| Feeding Behavior | 2 | 2019 | 461 | 0.140 |
Why?
|
| Hippocampus | 2 | 2021 | 591 | 0.140 |
Why?
|
| Middle Aged | 11 | 2016 | 11819 | 0.140 |
Why?
|
| Health Surveys | 3 | 2010 | 401 | 0.140 |
Why?
|
| Adipogenesis | 1 | 2018 | 13 | 0.140 |
Why?
|
| Entorhinal Cortex | 1 | 2018 | 12 | 0.140 |
Why?
|
| Anti-Obesity Agents | 1 | 2018 | 11 | 0.140 |
Why?
|
| Socioeconomic Factors | 4 | 2014 | 1221 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2018 | 1010 | 0.140 |
Why?
|
| Adipocytes | 1 | 2018 | 58 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 188 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 515 | 0.130 |
Why?
|
| Health Status Disparities | 3 | 2019 | 705 | 0.130 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 5 | 0.130 |
Why?
|
| Health Behavior | 3 | 2017 | 568 | 0.130 |
Why?
|
| Carotid Artery, External | 1 | 2016 | 5 | 0.130 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 14 | 0.130 |
Why?
|
| Adenoviridae | 1 | 2016 | 62 | 0.130 |
Why?
|
| Diet Surveys | 1 | 2016 | 97 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 979 | 0.130 |
Why?
|
| Memory | 1 | 2018 | 175 | 0.130 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 410 | 0.130 |
Why?
|
| Dementia | 1 | 2018 | 155 | 0.130 |
Why?
|
| Cell Line | 1 | 2020 | 1416 | 0.130 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 37 | 0.120 |
Why?
|
| Gene Transfer Techniques | 1 | 2016 | 53 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2016 | 165 | 0.120 |
Why?
|
| Adolescent Development | 1 | 2016 | 39 | 0.120 |
Why?
|
| Social Support | 2 | 2011 | 438 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 516 | 0.120 |
Why?
|
| Dentate Gyrus | 1 | 2015 | 42 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 1051 | 0.110 |
Why?
|
| Neoplasms | 2 | 2024 | 1341 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2015 | 127 | 0.110 |
Why?
|
| Weight Gain | 2 | 2014 | 138 | 0.110 |
Why?
|
| Aging | 2 | 2019 | 764 | 0.110 |
Why?
|
| Sesquiterpenes | 1 | 2014 | 38 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2014 | 43 | 0.110 |
Why?
|
| Decision Making | 1 | 2016 | 242 | 0.100 |
Why?
|
| Trauma Severity Indices | 2 | 2012 | 31 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2016 | 587 | 0.090 |
Why?
|
| Confidence Intervals | 3 | 2011 | 162 | 0.090 |
Why?
|
| Violence | 1 | 2012 | 133 | 0.090 |
Why?
|
| Parent-Child Relations | 2 | 2016 | 125 | 0.090 |
Why?
|
| Exercise | 1 | 2017 | 674 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 1554 | 0.090 |
Why?
|
| Research Design | 2 | 2022 | 370 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2012 | 190 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 532 | 0.090 |
Why?
|
| Health | 1 | 2010 | 30 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2011 | 51 | 0.080 |
Why?
|
| Self-Injurious Behavior | 1 | 2010 | 25 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2011 | 40 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2016 | 1516 | 0.080 |
Why?
|
| Minority Groups | 1 | 2014 | 663 | 0.070 |
Why?
|
| Massachusetts | 1 | 2008 | 35 | 0.070 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 729 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2020 | 142 | 0.070 |
Why?
|
| Censuses | 1 | 2007 | 28 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 56 | 0.070 |
Why?
|
| Survivors | 1 | 2008 | 152 | 0.060 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 512 | 0.060 |
Why?
|
| Naphthyridines | 1 | 2025 | 5 | 0.060 |
Why?
|
| Phenazines | 1 | 2025 | 6 | 0.060 |
Why?
|
| Psychometrics | 1 | 2007 | 350 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 85 | 0.060 |
Why?
|
| Asthma | 1 | 2009 | 410 | 0.060 |
Why?
|
| Saliva | 1 | 2025 | 115 | 0.050 |
Why?
|
| Wound Healing | 1 | 2024 | 82 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2004 | 124 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2025 | 134 | 0.050 |
Why?
|
| Quality of Life | 1 | 2008 | 599 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2024 | 403 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2024 | 686 | 0.050 |
Why?
|
| Muscles | 1 | 2022 | 84 | 0.050 |
Why?
|
| Incidence | 2 | 2018 | 1054 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 3077 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2008 | 583 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 54 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2021 | 41 | 0.040 |
Why?
|
| Sexual Partners | 2 | 2016 | 325 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2008 | 2485 | 0.040 |
Why?
|
| Infant | 1 | 2004 | 1143 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 168 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2020 | 3 | 0.040 |
Why?
|
| Adenine | 1 | 2020 | 48 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2020 | 44 | 0.040 |
Why?
|
| Risk | 2 | 2011 | 289 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2020 | 57 | 0.040 |
Why?
|
| Sex Factors | 2 | 2016 | 1008 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 112 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 181 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 255 | 0.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2018 | 7 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2018 | 14 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 26 | 0.040 |
Why?
|
| Aged | 3 | 2008 | 7982 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 487 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2018 | 17 | 0.040 |
Why?
|
| Menu Planning | 1 | 2017 | 8 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 428 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 24 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2018 | 55 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2598 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2019 | 253 | 0.030 |
Why?
|
| Marketing | 1 | 2017 | 44 | 0.030 |
Why?
|
| Amides | 1 | 2018 | 72 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2018 | 139 | 0.030 |
Why?
|
| Pyridines | 1 | 2018 | 134 | 0.030 |
Why?
|
| Rats, Inbred OLETF | 1 | 2016 | 5 | 0.030 |
Why?
|
| Incretins | 1 | 2016 | 2 | 0.030 |
Why?
|
| Homosexuality | 1 | 2016 | 35 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 51 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2019 | 526 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2016 | 41 | 0.030 |
Why?
|
| Venoms | 1 | 2016 | 18 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 683 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 92 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 237 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 206 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 526 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1737 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 638 | 0.030 |
Why?
|
| Self Concept | 1 | 2016 | 170 | 0.030 |
Why?
|
| Neuroglia | 1 | 2015 | 131 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 181 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2018 | 633 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 350 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 201 | 0.030 |
Why?
|
| California | 1 | 2016 | 531 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2014 | 166 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 157 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 1737 | 0.030 |
Why?
|
| Depression | 1 | 2021 | 837 | 0.030 |
Why?
|
| Peptides | 1 | 2016 | 357 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 303 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 224 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 1452 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 387 | 0.020 |
Why?
|
| Parents | 1 | 2016 | 359 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 640 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 280 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 491 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1066 | 0.020 |
Why?
|
| Rats | 1 | 2020 | 3701 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 115 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 438 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1112 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2011 | 53 | 0.020 |
Why?
|
| Neurons | 1 | 2018 | 1246 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 875 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1420 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 972 | 0.020 |
Why?
|
| Death Certificates | 1 | 2010 | 15 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2010 | 133 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 242 | 0.020 |
Why?
|
| Chicago | 1 | 2009 | 30 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1541 | 0.020 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 249 | 0.020 |
Why?
|
| Nurse Clinicians | 1 | 2008 | 2 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 236 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 249 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2008 | 95 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 708 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 348 | 0.020 |
Why?
|
| Mexico | 1 | 2009 | 286 | 0.020 |
Why?
|
| Life Change Events | 1 | 2008 | 107 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 154 | 0.020 |
Why?
|
| Crime Victims | 1 | 2008 | 77 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 311 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2008 | 245 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 174 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2010 | 359 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 2012 | 483 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 164 | 0.020 |
Why?
|
| Comorbidity | 1 | 2008 | 725 | 0.020 |
Why?
|
| Hypertension | 1 | 2012 | 823 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 727 | 0.010 |
Why?
|
| Mental Health | 1 | 2008 | 363 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 2803 | 0.010 |
Why?
|